Golden Road Advisors LLC Takes $304,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Golden Road Advisors LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 578 shares of the healthcare conglomerate’s stock, valued at approximately $304,000. UnitedHealth Group comprises approximately 0.3% of Golden Road Advisors LLC’s investment portfolio, making the stock its 26th largest position.

Several other large investors have also modified their holdings of the business. Bell Investment Advisors Inc raised its holdings in shares of UnitedHealth Group by 4.8% in the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 24 shares during the period. Verdence Capital Advisors LLC increased its holdings in UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after purchasing an additional 342 shares during the period. Bellecapital International Ltd. increased its holdings in UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after purchasing an additional 193 shares during the period. Rise Advisors LLC increased its holdings in UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after purchasing an additional 163 shares during the period. Finally, Gradient Investments LLC increased its holdings in UnitedHealth Group by 6.3% during the 4th quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after purchasing an additional 5,023 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on UNH. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, June 12th. Bank of America reaffirmed a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Robert W. Baird initiated coverage on UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. Finally, Wells Fargo & Company lowered their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Stock Down 1.6 %

UnitedHealth Group stock opened at $489.16 on Tuesday. The stock has a market capitalization of $450.22 billion, a price-to-earnings ratio of 29.90, a PEG ratio of 1.44 and a beta of 0.58. The stock has a 50 day moving average of $494.22 and a two-hundred day moving average of $505.48. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the business posted $6.26 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date is Monday, June 17th. UnitedHealth Group’s dividend payout ratio is 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.